N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide and Pneumonia--Viral

N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide has been researched along with Pneumonia--Viral* in 1 studies

Other Studies

1 other study(ies) available for N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide and Pneumonia--Viral

ArticleYear
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
    Science (New York, N.Y.), 2020, 06-19, Volume: 368, Issue:6497

    SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the etiological agent responsible for the global COVID-19 (coronavirus disease 2019) outbreak. The main protease of SARS-CoV-2, M

    Topics: Animals; Antiviral Agents; Betacoronavirus; Catalytic Domain; Chlorocebus aethiops; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; Cysteine Endopeptidases; Dogs; Drug Design; Drug Evaluation, Preclinical; Female; Humans; Male; Mice; Molecular Structure; Pandemics; Pneumonia, Viral; Protein Structure, Tertiary; Rats, Sprague-Dawley; SARS-CoV-2; Toxicity Tests; Vero Cells; Viral Nonstructural Proteins

2020